Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Germ cell cancer.

R T Oliver1

  • 1St. Bartholomew's Hospital and The Royal London School of Medicine, Queen Mary and Westfield College, West Smithfield, UK.

Current Opinion in Oncology
|May 18, 1999
PubMed
Summary
This summary is machine-generated.

Germ cell cancer development involves prenatal estrogen priming and postpubertal cell cycle events. New markers aid in identifying poor-risk tumors, guiding improved treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-agent carboplatin AUC10 for metastatic seminoma with IGCCCG good prognosis disease; a feasibility study of the Orchid Clinical Trials Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Aphorisms in cancer surgery.

Annals of the Royal College of Surgeons of England·2009
Same author

Prognostic factors for renal cell carcinoma.

Cancer treatment reviews·2008
Same author

Introduction: Clonal evolution in bladder cancer: a scientific and clinical perspective.

Cancer surveys·2004
Same author

Squamous change in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer.

Cancer surveys·2004
Same author

Malignancy associated papillomaviruses and morphology of human bladder cancer.

Cancer surveys·2004
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Developmental Biology
  • Molecular Pathology

Background:

  • Germ cell tumors (GCTs) arise from germ cells and are influenced by both prenatal and postpubertal factors.
  • Understanding the molecular mechanisms underlying GCT development is crucial for improving diagnosis and treatment.
  • Previous research has highlighted the role of hormonal influences and genetic alterations in GCT pathogenesis.

Purpose of the Study:

  • To synthesize current knowledge on the interplay of prenatal and postpubertal factors in germ cell cancer development.
  • To explore the molecular events driving tumor initiation and progression.
  • To discuss the implications of new findings for tumor classification, risk stratification, and therapeutic strategies.

Main Methods:

  • Review and synthesis of findings presented at the Fourth Workshop on Carcinoma in situ.

Related Experiment Videos

  • Analysis of molecular pathways involved in germ cell development and transformation.
  • Evaluation of emerging biomarkers for risk stratification.
  • Discussion of clinical trial outcomes and their impact on treatment paradigms.

    • Main Results:

    • Estrogen-mediated prenatal priming of germ cells predisposes them to postpubertal transformation.
    • Tumorigenesis involves cyclin D2-driven cell cycle re-entry of arrested spermatocytes.
    • Novel biomarkers such as FGF4, CD30, and OCT-4 aid in identifying poor-risk embryonal carcinoma.
    • Chemotherapy demonstrates superior efficacy over radiation for seminoma, which is more chemosensitive than non-seminoma.

    Conclusions:

    • A comprehensive understanding of GCT development integrates prenatal hormonal influences with postpubertal molecular events.
    • Emerging biomarkers necessitate a re-evaluation of histopathology for improved risk assessment.
    • Optimizing chemotherapy use requires enhanced pathologic definition to minimize overtreatment and maximize therapeutic benefit.
    • Future trials should prioritize re-examining treatment approaches for poor-risk GCTs, given recent clinical trial results.